Apg Asset Management N.V. Bei Gene, Ltd. Transaction History

Apg Asset Management N.V.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$215.53 - $274.5 $64,659 - $82,350	-300 Reduced 18.75%	1,300 $280,000
Q4 2022 Feb 14, 2023	SELL	$125.51 - $229.3 $342,767 - $626,218	-2,731 Reduced 63.06%	1,600 $352,000
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $121,110 - $216,050	-1,000 Reduced 18.76%	4,331 $670,000
Q1 2022 May 12, 2022	SELL	$146.52 - $269.56 $58,608 - $107,824	-400 Reduced 6.98%	5,331 $904,000
Q4 2021 Feb 11, 2022	BUY	$248.56 - $389.34 $149,136 - $233,603	600 Added 11.69%	5,731 $1.37 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $413,088 - $667,196	-1,655 Reduced 24.39%	5,131 $1.61 Million
Q2 2021 Aug 13, 2021	SELL	$292.75 - $367.01 $4.79 Million - $6.01 Million	-16,364 Reduced 70.69%	6,786 $1.96 Million
Q1 2021 May 14, 2021	SELL	$260.64 - $382.12 $586,440 - $859,770	-2,250 Reduced 8.86%	23,150 $6.86 Million
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $1.26 Million - $1.8 Million	-5,700 Reduced 18.33%	25,400 $5.36 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $1.34 Million - $2.03 Million	-7,100 Reduced 18.59%	31,100 $7.6 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $1.36 Million - $2.15 Million	11,000 Added 40.44%	38,200 $6.41 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $3.31 Million - $4.71 Million	27,200 New	27,200 $3.35 Million

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.